Stay updated on XMT-1660 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.

Latest updates to the XMT-1660 in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for Emi-Le in participants with solid tumors is now displayed, including study design, eligibility requirements, contact information, and recruiting locations. The record also outlines the trial’s safety and efficacy measures.SummaryDifference85%

- Check13 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAn NIH-wide notice was added about the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected study record content. This indicates restricted access rather than updated study details.SummaryDifference21%

Stay in the know with updates to XMT-1660 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1660 in Solid Tumors Clinical Trial page.